Management of Retained Central Venous Catheters

Why This Problem Exists

Central venous catheters placed for long-term chemotherapy or parenteral nutrition eventually need removal. Most come out cleanly. But in 5 to 15% of removals, something goes wrong—the catheter adheres to the vessel wall, fractures during traction, or requires more than simple withdrawal 0:32. In 0.2 to 2% of cases, a fragment stays behind 0:57. The question for the removing surgeon is whether that fragment demands retrieval or can be left in place.

The Core Clinical Problem

A catheter fragment retained in the central venous system is foreign material in direct contact with blood. The theoretical risks are thrombosis and infection. The practical question is whether those risks justify the procedural hazards of going after it—either through surgical venotomy with its bleeding risk 2:10, or through endovascular snaring with its risks of complete catheter embolization or procedure-induced thrombosis 2:16 2:16. This is a risk-benefit calculation with limited long-term data.

Risk Factors for Retention

Three factors increase the likelihood a catheter will fracture or adhere during removal. First, chemotherapy infusion through the line 1:12—the caustic agents may damage the catheter material or provoke vessel wall reaction. Second, indwelling duration exceeding 18 months 1:12. Third, polyurethane catheter material compared to silicone 1:25. Power ports are polyurethane devices 1:31, which matters for initial catheter selection in patients expected to need long-term access.

For a patient starting chemotherapy with an anticipated treatment duration measured in years, one discussant recommends silastic catheters over polyurethane 1:46. The tradeoff is diameter—silastic catheters require a larger bore for a given lumen size 3:08—but the retention risk appears lower.

Management When Retention Occurs

When a catheter fractures during removal and a fragment remains in the central circulation, three options exist: surgical retrieval via venotomy, endovascular retrieval via interventional radiology, or conservative management. The evidence base for choosing among them is observational.

Surgical venotomy carries bleeding risk 2:10. Endovascular retrieval carries the risk of complete catheter fracture with distal embolization or thrombosis during the procedure itself 2:16 2:16. Against these procedural risks, the natural history data are striking: multiple studies following patients with retained catheter fragments for periods ranging from months to five years found no complications 2:31. Specifically, no thrombosis 2:42 and no infections 2:42. One discussant states there has never been a reported problem from leaving a catheter fragment in place 3:26, though the same discussant acknowledges the absence of long-term data 3:26.

This is not a randomized comparison. The patients who had fragments left behind may differ systematically from those who underwent retrieval attempts. But the observational data suggest that conservative management—simply leaving the fragment—is a reasonable default, particularly when the fragment is small, the patient is asymptomatic, and retrieval would require venotomy or an interventional procedure with its attendant risks.

What Remains Uncertain

The follow-up in the available studies extends to five years 2:31, which is not trivial but also not a lifetime. Whether retained catheter fragments pose late risks—decades-later thrombosis, endocarditis in the setting of bacteremia, or calcification—is unknown. The discussion does not address whether fragment location matters (right atrium versus superior vena cava versus subclavian vein), whether fragment size influences risk, or whether anticoagulation or antiplatelet therapy should be considered in patients with retained material.

The claim that polyurethane material increases retention risk 1:25 is observational, and one discussant notes the concern that this association could reflect the fact that most catheters placed are polyurethane rather than a true material effect. The recommendation to prefer silastic catheters for long-term chemotherapy 1:46 rests on this uncertain association.

When to Involve This Decision

For a surgeon removing a long-term central catheter, the decision point is intraoperative: the catheter fractures, and a fragment remains. The immediate question is whether to extend the dissection, call interventional radiology, or close and observe. Based on the evidence discussed, observation is defensible unless the fragment is causing acute symptoms or the clinical context creates unusual thrombotic or infectious risk.

For a surgeon placing a new catheter in a patient beginning long-term chemotherapy, the decision point is device selection. If the expected indwelling time exceeds 18 months and chemotherapy will be infused through the line, silastic catheters may reduce retention risk at the cost of requiring larger veins for placement 1:46 3:08.

The referring clinician's role is recognizing that a retained catheter fragment, while undesirable, is not an automatic indication for retrieval. The procedural risks of going after it may exceed the risks of leaving it alone.